High in vivo expression of interleukin‐17 receptor in synovial endothelial cells and chondrocytes from arthritis patients
Tóm tắt
Từ khóa
Tài liệu tham khảo
Yao Z, Fanslow WC, Seldin MF et al. Herpesvirus Saimiri encodes a new cytokine, IL‐17, which binds to a novel cytokine receptor. Immunity1995;3:811–21.
Yao Z, Painter SL, Fanslow WC et al. Human IL‐17: a novel cytokine derived from T cells. J Immunol1995;155:5483–6.
Fossiez F, Djossou O, Chomarat P et al. T cell interleukin‐17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med1996;183:2593–603.
Jovanovic DV, Di Battista JA, Martel‐Pelletier J et al. IL‐17 stimulates the production and expression of proinflammatory cytokines, IL‐beta and TNF‐alpha, by human macrophages. J Immunol1998;160:3513–21.
Attur MG, Patel RN, Abramson SB, Amin AR. Interleukin‐17 up‐regulation of nitric oxide production in human osteoarthritis cartilage. Arthritis Rheum1997; 40:1050–3.
Martel‐Pelletier J, Mineau F, Jovanovic D, Di Battista JA, Pelletier JP. Mitogen‐activated protein kinase and nuclear factor κB together regulate interleukin‐17‐induced nitric oxide production in human osteoarthritic chondrocytes. Possible role of transactivating factor mitogen‐activated protein kinase‐activated protein kinase (MAPKAPK). Arthritis Rheum1999;42:2399–409.
Chabaud M, Durand JM, Buchs N et al. Human interleukin‐17: A T cell‐derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum1999;42:963–70.
Kotake S, Udagawa N, Takahashi N et al. IL‐17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest1999;103:1345–52.
Yao Z, Spriggs MK, Derry JMJ et al. Molecular characterization of the human interleukin (IL)‐17 receptor. Cytokine1997;9:794–800.
Shalom‐Barak T, Quach J, Lotz M. Interleukin‐17‐induced gene expression in articular chondrocytes is associated with activation of mitogen‐activated protein kinases and NF‐κB. J Biol Chem1998;273:27467–73.
Altman R, Asch E, Bloch D et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum1986; 29:1039–49.
Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum1988;31:315–24.
Pasquali‐Ronchetti I, Frizziero L, Guerra D et al. Aging of the human synovium: an in vivo and ex vivo morphological study. Semin Arthritis Rheum1992;21:400–14.
Cush JJ, Pietschmann P, Oppenheimer‐Marks N, Lipsky PE. The intrinsic migratory capacity of memory T cells contributes to their accumulation in rheumatoid synovium. Arthritis Rheum1992;35:1434–44.
Go C, Miller J. Differential induction of transcription factors that regulate the interleukin 2 gene during anergy induction and restimulation. J Exp Med1992; 175:1327–36.
Kang SM, Beverly B, Tran AC, Brorson K, Schwartz RH, Lenardo MJ. Transactivation by AP‐1 is a molecular target of T cell clonal anergy. Science1992; 257:1134–8.
Firenstein GS, Zvaifler NJ. How important are T cells in chronic rheumatoid synovitis. Arthritis Rheum1990; 33:768–73.
Fox DA. The role of T cells in the immunopathogenesis of rheumatoid arthritis. New perspective. Arthritis Rheum1997;40:598–608.
Pitzalis C, Kingsley G, Lanchbury JSS, Murphy J, Panayi GS. Expression of HLA‐DR, DQ and DP antigens and interleukin‐2 receptor on synovial fluid T lymphocyte subsets in rheumatoid arthritis: evidence for frustrated activation. J Rheumatol1987;14:662–6.
Balsa A, Dixey J, Sansom DM, Maddison PJ, Hall ND. Differential expression of the costimulatory molecules B7.1 (CD80) and B7.2 (CD86) in rheumatoid synovial tissue. Br J Rheumatol1996;35:33–7.
McInnes IB, Leung BP, Sturrock RD, Field M, Liew FY. Interleukin‐15 mediates T cell‐dependent regulation of tumor necrosis factor‐α production in rheumatoid arthritis. Nat Med1997;3:189–95.
Ziolkowska M, Koc A, Luszczykiewicz G et al. High levels of IL‐17 in rheumatoid arthritis patients: IL‐15 triggers in vitro IL‐17 production via cyclosporin A‐sensitive mechanism. J Immunol2000;164:2832–8.
Bläß S, Engel JM, Burmester GR. The immunologic homunculus in rheumatoid arthritis. Arthritis Rheum1999;42:2499–506.
Nepom GT, Nepom BS. Prediction of susceptibility to rheumatoid arthritis by human leukocyte antigen genotyping. Rheum Dis Clin North Am1992;18:785–92.
Winchester R. The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol1994;56:389–466.
Reveille JD, Alarcon GS, Fowler SE et al. HLA‐DRB1 genes and disease severity in rheumatoid arthritis. The MIRA Trial group. Minocycline in rheumatoid arthritis. Arthritis Rheum1996;39:1802–7.
Teunissen MB, Koomen CW, de Waal Malefyt R, Wierenga EA, Bos JD. Interleukin‐17 and interferon‐gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol1998;111:645–9.
Albanesi C, Cavani A, Girolimoni G. IL‐17 is produced by nickel‐specific T lymphocytes and regulates ICAM‐1 expression and chemokine production in human keratinocytes: synergistic or antagonist effect with IFN‐γ and TNF‐α. J Immunol1999;162:494–502.
Li H, Chen J, Huang A et al. Cloning and characterization of IL‐17B and IL‐17C, two new members of the IL‐17 cytokine family. Proc Natl Acad Sci USA2000;97:773–8.
Tocci MJ, Schmidt A. Interleukin‐1: structure and function. In: Remick DG, Friedland JS, eds. Cytokines in health and disease, 2nd edition. New York: Marcel Dekker, 1997:1–27.
Cope AP, Gibbons DL, Aderka D et al. Differential regulation of tumour necrosis factor receptors (TNF‐R) by IL‐4; upregulation of P55 and P75 TNF‐R on synovial joint mononuclear cells. Cytokine1993;5:205–12.